This five-part series examines current trends in home health and hospice M&A as the sector enters 2026, including valuation discipline, compliance and clinical risk, the role of artificial intelligence, and how deal structure and preparation are affecting transaction outcomes. Part 3 examines why buyers are treating artificial intelligence, workflow automation, and operational reporting as indicators of whether home health and hospice platforms can scale efficiently while protecting margins….
By: Arnall Golden Gregory LLP
By: Arnall Golden Gregory LLP
